Evaluation of the R&D Program
|Institution:||Nova Public Policy|
|Chief Investigator:||Professor Rosemary Calder|
It is a requirement under the Third Community Pharmacy Agreement to evaluate the CPA R&D Grants Program. The purpose of this evaluation is to determine how effective the Third CPA R&D Program has been in achieving its objectives.
The evaluation will serve to inform Guild and Government decisions about the future objectives and funding of the program including: the continuation of the program, whether the program is meeting its stated aims and objectives, and whether it is still appropriate and fulfilling a research and evaluation need.